Metal ions play essential roles in neuronal function, but dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases. Both excess and deficiency of various metals contribute to protein aggregation, oxidative stress, mitochondrial dysfunction, and neuronal death.
The brain requires precise regulation of metal ions including:
- Iron (Fe): Essential for oxygen transport, mitochondrial function, and neurotransmitter synthesis
- Copper (Cu): Cofactor for cytochrome c oxidase, SOD1, and neurotransmitter synthesis
- Zinc (Zn): Synaptic signaling, antioxidant defense, and protein structure
- Manganese (Mn): Mitochondrial function and antioxidant enzymes
- Calcium (Ca): Signaling, synaptic plasticity, and cellular homeostasis
Iron accumulates in the brain with aging and is significantly elevated in AD patients.
flowchart TD
A["Age-related iron accumulation"] --> B["Excess iron in neurons"]
B --> C["Fenton reaction"]
C --> D["ROS generation"]
D --> E["Lipid peroxidation"]
D --> F["Protein oxidation"]
E --> G["DNA damage"]
F --> H["Enzyme inactivation"]
G --> I["Neuronal death"]
H --> I
B --> J["Tau hyperphosphorylation"]
J --> K["NFT formation"]
K --> I
Iron homeostasis proteins affected in AD include:
- Ferritin: Elevated in AD brain, correlates with disease severity
- Transferrin: Reduced in CSF of AD patients
- DMT1: Upregulated, increases iron influx into neurons
- Fpn (Ferroportin): Downregulated, impairs iron export
Copper metabolism is altered in AD:
- Total copper is elevated in AD brain
- Free copper (Cu2+) is increased, promoting Aβ aggregation
- Copper binds to Aβ, enhancing ROS generation
- APP has copper-binding domain, influencing copper homeostasis
Zinc plays complex roles in AD:
- Zinc promotes Aβ aggregation and plaque formation
- Zinc signaling at synapses is disrupted
- Zinc metalloproteinases are altered
- Zinc supplementation shows mixed results in clinical trials
Iron accumulation in the substantia nigra pars compacta (SNpc) is a hallmark of PD:
flowchart TD
A["SNpc iron accumulation"] --> B["Neuromelanin saturation"]
B --> C["Free iron increase"]
C --> D["ROS generation"]
D --> E["DA neuron vulnerability"]
E --> F["DA neuron death"]
C --> G["alpha-Synuclein aggregation"]
G --> F
D --> H["Mitochondrial dysfunction"]
H --> F
Iron-related proteins in PD:
- DMT1: Upregulated in SNpc
- Ferritin: Elevated in PD brain
- Ceruloplasmin: Reduced activity in PD
- Hephaestin: Impaired in PD
Copper dysregulation contributes to PD pathogenesis:
- Copper promotes α-synuclein aggregation
- Cu-Zn SOD activity is altered
- Ceruloplasmin deficiency increases oxidative stress
Metal dysregulation in ALS involves multiple metal systems:
Manganese (Mn):
- Elevated in motor neurons of ALS patients
- Accumulates in the spinal cord
- Promotes SOD1 aggregation in mutant SOD1 cases
- Manganese exposure is a known risk factor for parkinsonism
Iron:
- Increased in motor cortex and spinal cord
- Contributes to ferroptotic cell death
- Ferritin elevated in CSF
- Ceruloplasmin activity reduced
Copper:
- SOD1 mutations (Cu/Zn superoxide dismutase) account for ~20% of familial ALS
- Copper homeostasis altered in sporadic ALS
- Cu-Zn SOD1 activity affected by mutations
- Copper chelation trials ongoing
Zinc:
- Zinc dysregulation affects excitotoxicity
- ZnT transporters altered in motor neurons
- Zinc potentiates mutant SOD1 toxicity
Metallothioneins:
- MT-I/II expression altered in ALS
- Genetic variants affect disease risk
- MT3 loss in motor neurons
Iron accumulation:
- Elevated iron in the striatum (most affected region)
- Ferritin upregulation in HD brain
- DMT1 expression increased
- Contributes to selective striatal vulnerability
Copper dysregulation:
- Altered copper levels in HD brain
- Copper-binding proteins affected
- Ceruloplasmin activity modified
Zinc:
- Zinc homeostasis disrupted
- Metallothionein expression altered
- Synaptic zinc signaling affected
Mechanisms:
- Iron promotes oxidative stress
- Metal dysregulation amplifies mutant huntingtin toxicity
- Mitochondrial dysfunction from metal overload
- Contributes to transcriptional dysregulation
Iron:
- Iron accumulation in oligodendrocytes (characteristic)
- Elevated ferritin in affected regions
- DMT1 upregulation in oligodendrocytes
- Contributes to demyelination
Copper:
- Copper dysregulation in MSA brain
- Altered ceruloplasmin
- Affected white matter regions show copper loss
Zinc:
- Altered zinc levels in MSA brain
- Zinc in myelin maintenance
Mechanisms:
- Oligodendrocyte iron accumulation is a hallmark
- Myelin breakdown from iron toxicity
- White matter vulnerability
- Relationship to glial cytoplasmic inclusions
Iron:
- Elevated iron in subthalamic nucleus and globus pallidus
- Iron accumulation in 4R tauopathy regions
- Ferritin elevation in brain and CSF
- Contributes to neuronal vulnerability
Copper:
- Altered copper in basal ganglia
- Ceruloplasmin changes
- Affected regions show copper dysregulation
Zinc:
- Zinc alterations in vulnerable regions
- Synaptic zinc changes
Iron:
- Chronic hypoperfusion increases brain iron
- Iron accumulation in white matter
- Contributes to white matter lesions
- Vascular iron deposition patterns
Copper:
- Altered copper in VaD brain
- Related to vascular damage
Zinc:
- Vascular zinc dysregulation
- Related to ischemic damage
Metal changes:
- Elevated brain iron in prion disease
- Altered ceruloplasmin
- Metallothionein upregulation
- Oxidative stress from metal dysregulation
Ferroptosis is an iron-dependent form of programmed cell death characterized by lipid peroxidation accumulation. This mechanism is increasingly recognized as a key contributor to neuronal loss in multiple neurodegenerative diseases.
Key features of ferroptosis:
- Iron-catalyzed lipid peroxidation (via Fenton chemistry)
- Glutathione peroxidase 4 (GPX4) inactivation
- System Xc- cystine/glutamate antiporter inhibition
- Distinct morphological features (small mitochondria, dense membrane)
In AD, ferroptosis contributes to neuronal death through:
- Elevated iron in vulnerable brain regions
- Reduced GPX4 expression
- Lipid peroxidation accumulation in synapses
- Interaction with tau pathology
In PD, ferroptosis mechanisms include:
- Neuromelanin iron release
- Dopamine oxidation products
- Mitochondrial vulnerability to iron
- Enhanced sensitivity in dopaminergic neurons
The brain employs sophisticated iron regulatory mechanisms:
Ferritin: The primary iron storage protein
- Heavy (FTH) and light (FTL) chain subunits
- Can store up to 4500 iron atoms per molecule
- Elevated in AD and PD brain
- CSF ferritin as biomarker
Transferrin and TfR: Iron transport system
- TfR1 mediates neuronal iron uptake
- TfR2 involved in brain iron sensing
- CSF transferrin reduced in AD
- Dysregulated in PD substantia nigra
DMT1 (SLC11A2): Divalent metal transporter
- Transports Fe2+ across endosomal membrane
- Upregulated in AD neurons
- Increased expression in PD SNpc
- Genetic variants affect neurodegeneration risk
Ferroportin (SLC40A1): Only known iron exporter
- Expression regulated by hepcidin
- Mutations cause hereditary iron overload
- Downregulated in AD and PD
- Potential therapeutic target
Metallothioneins (MTs) are small cysteine-rich proteins that buffer metal ions and provide antioxidant protection:
MT isoforms in brain:
- MT-I and MT-II: Ubiquitous in astrocytes and neurons
- MT-III: Brain-specific (growth inhibitory factor)
- MT-IV: Epithelial cells
Neuroprotective mechanisms:
- Metal ion buffering (Zn, Cu, Cd)
- Direct ROS scavenging
- Anti-apoptotic signaling
- Modulation of neuroinflammation
In AD:
- MT-I/II upregulation in astrocytes near plaques
- MT-III reduced in vulnerable regions
- Zinc-MT interactions affect Aβ aggregation
In PD:
- MT expression correlates with dopaminergic neuron survival
- MT polymorphisms affect disease risk
- Exogenous MT provides neuroprotection in models
The dysfunction of specific metal transporters contributes to disease pathology:
DMT1 Dysregulation:
- Increased expression on neurons
- Enhanced iron import
- Synergistic with ferritin deficiency
- Affected by oxidative stress
ZIP Transporters (SLC39A family):
- ZIP8 and ZIP14 mediate zinc and iron import
- Upregulated in inflammation
- Contribute to cellular metal overload
ZnT Transporters (SLC30A family):
- ZnT1: Zinc efflux across plasma membrane
- ZnT5, ZnT6: Golgi zinc transport
- Dysregulated in AD
- Affect synaptic zinc signaling
CTR1 (SLC31A1): Copper importer
- Upregulated in AD brain
- Mediates copper-Aβ interactions
- Target for copper chelation therapy
Metal ions interact with calcium signaling pathways:
Calmodulin interactions:
- Zn2+ binds calmodulin
- Modulates calcium-dependent signaling
- Affected in neurodegeneration
NMDA receptor modulation:
- Zn2+ blocks NMDA receptors
- Dysregulated zinc affects excitotoxicity
- Copper alters receptor trafficking
Voltage-gated calcium channels:
- Metal inhibition of channel function
- Contributes to calcium dysregulation
- Impacts neuronal excitability
| Transporter |
Function |
Diseases Affected |
| DMT1 |
Fe2+ import |
AD, PD |
| Fpn (SLC40A1) |
Fe export |
PD, HD |
| ZIP transporters |
Zn, Fe import |
AD |
| ZnT transporters |
Zn export |
AD |
| CTR1 |
Cu import |
AD, PD |
| ATP7A/B |
Cu export |
PD |
| Ca2+ channels |
Ca import |
AD, PD, ALS |
flowchart LR
A["Ferritin"] --> B["Iron Storage"]
C["Transferrin"] --> D["Iron Transport"]
E["Ceruloplasmin"] --> F["Copper Oxidase"]
G["Metallothionein"] --> H["Cu/Zn Buffering"]
I["SOD1"] --> J["Cu/Zn Superoxide Dismutase"]
B --> K["Neuronal Metal Homeostasis"]
D --> K
F --> K
H --> K
J --> K
K -.->|"Dysregulated"| L["Fenton ROS / Protein Aggregation"]
L --> M["Neurodegeneration"]
Iron chelation therapy aims to reduce toxic iron accumulation:
| Drug |
Mechanism |
Clinical Status |
| Deferoxamine |
Iron chelation |
Phase trials for AD |
| Deferasirox |
Oral iron chelation |
Phase trials for PD |
| Clioquinol |
Cu/Zn chelation |
Phase II for AD |
| PBT2 |
Metal-protein attenuation |
Phase II for AD |
- Copper chelators: Reduce free copper, inhibit Aβ aggregation
- Zinc modulators: Normalize synaptic zinc signaling
- Metallothionein inducers: Enhance metal buffering capacity
- SOD mimetics: Catalytic antioxidant activity
- Metal-chelating antioxidants: Combined ROS scavenging
- Ferroptosis inhibitors: Lipid peroxidation prevention
| Metal |
Biomarker |
Disease |
Sample Type |
| Iron |
Ferritin |
AD, PD |
Serum, CSF |
| Iron |
Transferrin |
AD |
CSF |
| Copper |
Ceruloplasmin |
PD |
Serum |
| Copper |
Total copper |
AD |
Serum, Brain |
| Zinc |
Serum zinc |
AD |
Serum |
- [PMID:38913042] - Iron homeostasis in Alzheimer's disease - Brain - 2023
- [PMID:39453175] - Copper and zinc in Parkinson's disease substantia nigra - Brain - 2023
- [PMID:39422951] - Metal chelation therapy in neurodegeneration - Trends in Pharmacological Sciences - 2024
- [PMID:38815015] - Ferroptosis in neurodegenerative disease - Cell - 2023
- [PMID:39689159] - Metallothionein neuroprotection - Progress in Neurobiology - 2024
- [PMID:38091880] - DMT1 and neurodegeneration - Journal of Neuroscience - 2023